Neurology Perspective

 
 

  • Are You Sure Your Patient Is Alive?   Someone knows when a person has died, but a shocking lack of sharing that news is causing problems for clinicians, families, and health systems.
  • How Low Should You Go? Is Very Low LDL-C Safe? Drs Connie Newman and Seth Martin highlight the evidence supporting the safety of very low LDL-C levels, and how maintaining low levels protects against CV events such as MI and stroke.
  • Infographic: Doctors Grade Their EHR Systems Physicians reveal how well they think their employer's electronic health record (EHR) systems are or aren't delivering on certain key features.
  • Don't Let Bureaucracy Impede Research for ALS, Says Ethicist   Bioethicist Art Caplan discusses the proposed Promising Pathway Act, saying the focus should be on more research for ALS rather than moving forward with less evidence.
  • Wisdom From a Scottish GP: The Lost Art of Convalescence   The final Medicine and the Machine podcast guest, physician and author Gavin Francis, shares his approach to keeping his occupation rewarding and satisfying.
  • Air Filtration Best Intervention Against Respiratory Viruses?   Even mask "supporters" don't like having to wear them, so perhaps we can find a better way to protect us from respiratory viruses.
  • Myasthenia Gravis Highlights From AANEM 2023   Key data on myasthenia gravis from AANEM 2023 include results on the ADAPT+ study of efgartigimod, inequities in diagnosis, and eculizumab use in pregnancy, as reviewed by Dr Nicholas Silvestri.
  • 20 Best Holiday Gift Ideas for RNs and NPs From pampering their hard-working hands and feet to personalizing their work essentials, find the perfect present for your favorite nurse.
  • Fall Updates in Dementia, PD, and Stroke   Christoph Diener discusses interesting neurology studies published in October, spanning hearing loss and cognitive impairment, Parkinson's disease, and stroke.
  • Headache After Drinking Red Wine? This Could Be Why   If you pair Beaujolais or Pinot Noir with your turkey dinner, you might feel the effects on Black Friday. A recent study examines the mechanism behind red wine headaches.
  • To Anticoagulate or Not in Subclinical AF   John Mandrola and ARTESiA investigator Jeff Healey discuss the results and how they compare with the NOAH-AFNET-6 data on the use of DOACs in patients with short-duration AF.
  • Is Most Parkinson's Disease Man-Made?   Indu Subramanian interviews Ray Dorsey about the link between environmental toxins and Parkinson's disease and his advocacy work to end this disease.
  • AHA 2023 ARTESIA Doesn't Answer a Common Question in Cardiology The trial on apixaban vs aspirin in subclinical atrial fibrillation did not provide an easy answer on whether to anticoagulate patients with these common arrhythmias, writes John Mandrola, MD.
  • The Placebo Effect I recently had a generic cold. I usually get a cough that lasts a few weeks afterward, and like most people, I try to do something about it. So I load up on various over-the-counter remedies.
  • Infographic: Careers That Tempt Doctors to Leave Medicine Physicians who are thinking about leaving the practice of medicine reveal which nonclinical career options most interest them.
  • The Future of Medicine Is RNA   Short interfering RNA drugs could be the next big game changers in pharmacotherapeutics.
  • What to Tell Your Patients About Anti-amyloids for Alzheimer's Disease   Kathrin LaFaver and Meredith Wicklund discuss indications and contraindications for lecanemab and other anti-amyloids for Alzheimer's disease that may be coming soon.
  • Is It Time for Cardiologists to Treat Obesity?   Cardiologists Michelle O'Donoghue and Nicholas Marston discuss the "game changer" trial at AHA showing that GLP-1 agonist semaglutide reduced CV events in patients with ASCVD and overweight/obesity.
  • Pain Control: Tips for Managing Patient Expectations   Drs Neha Pathak and Daniel Clauw on how to manage patient expectations when it comes to pain control.
  • AHA 2023 ORBITA-2 Saves Interventional Cardiology, Questions Guidance The second sham-controlled trial of PCI in stable CAD brings relief to the field but challenges our understanding of angina and raises the bar for trials in other specialties, says John Mandrola, MD.
  • ESOC 2021